NCT00629590

Safety and Efficacy Pilot Study of AzaSite (Azithromycin) in Subjects With Blepharitis

A Single-Center, Open-Label, Randomized Pilot Study of the Safety and Efficacy of AzaSite® Ophthalmic Solution, 1% in Combination With Mechanical Therapy Versus Mechanical Therapy Alone for Two Weeks in Subjects With Posterior Blepharitis

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 20 (estimated)
• Sponsor: Merck Sharp & Dohme LLC · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to evaluate the safety and efficacy of AzaSite ophthalmic solution, 1% on signs and symptoms of blepharitis.

Conditions

• Blepharitis

Interventions

Type	Name	Description
DRUG	AzaSite®	ophthalmic solution; 1 drop in each eye BID for two days, then 1 drop in each eye QD for \~12 days

Timeline

• Start date: 2008-03-01
• Primary completion: 2008-07-01
• First posted: 2008-03-06
• Last updated: 2011-09-26

Locations

1 site across 1 country: United States